Lam Research Corp
(LRCX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,390,659 | 5,847,856 | 5,337,056 | 3,522,001 | 4,418,263 |
| Marketable Securities | N/A | N/A | N/A | 135,731 | 1,310,872 |
| Receivables | 3,378,071 | 2,519,250 | 2,823,376 | 4,313,818 | 3,026,430 |
| Inventories | 4,307,991 | 4,217,924 | 4,816,190 | 3,966,294 | 2,689,294 |
| Other current assets | 5 | 0 | -2 | 5 | 3 |
| TOTAL | $14,517,000 | $12,883,220 | $13,228,410 | $12,285,240 | $11,652,390 |
| Non-Current Assets | |||||
| PPE Net | 2,428,744 | 2,154,518 | 1,856,672 | 1,647,587 | 1,303,479 |
| Intangibles | 0 | 0 | 1,790,943 | 1,616,963 | 1,622,499 |
| Other Non-Current Assets | 4,399,521 | 3,706,990 | 1,905,616 | 1,645,847 | 1,313,787 |
| TOTAL | $6,828,265 | $5,861,508 | $5,553,231 | $4,910,397 | $4,239,765 |
| Total Assets | $21,345,260 | $18,744,730 | $18,781,640 | $17,195,630 | $15,892,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 754,311 | 504,814 | 8,358 | 7,381 | 11,349 |
| Accounts payable and accrued liabilities | 854,208 | 613,966 | 470,702 | 1,011,208 | 829,710 |
| Accrued Expenses | 2,394,366 | 1,801,877 | 2,010,637 | 1,974,272 | 1,719,483 |
| TOTAL | $6,568,425 | $4,338,438 | $4,184,918 | $4,564,759 | $3,527,867 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,730,194 | 4,478,520 | 5,003,183 | 4,998,449 | 4,990,333 |
| Deferred Revenues | 2,565,540 | 1,417,781 | 1,695,221 | 1,571,898 | 967,325 |
| Other Non-Current Liabilities | 1,185,022 | 1,388,316 | 1,383,370 | 1,354,058 | 1,346,764 |
| TOTAL | $4,915,216 | $5,866,836 | $6,386,553 | $6,352,507 | $6,337,097 |
| Total Liabilities | $11,483,640 | $10,205,270 | $10,571,470 | $10,917,270 | $9,864,964 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,265,621 | 1,298,760 | 1,325,117 | 1,369,878 | 1,419,537 |
| Common Shares | 1,268 | 1,304 | 133 | 137 | 143 |
| Retained earnings | 28,988,910 | 24,811,310 | 22,032,100 | 18,454,720 | 14,684,910 |
| Other shareholders' equity | -62,849 | -130,206 | -101,063 | -110,407 | -63,827 |
| TOTAL | $9,861,619 | $8,539,454 | $8,210,172 | $6,278,366 | $6,027,188 |
| Total Liabilities And Equity | $21,345,259 | $18,744,724 | $18,781,642 | $17,195,636 | $15,892,152 |